Top 10 Pharma MNCs To Hold 12% Of China Med Market, Up From 7%: IMS
This article was originally published in PharmAsia News
Executive Summary
IMS has predicted that the top 10 U.S. and European multinational pharma will hold 12% of 17 emerging medical markets including China, up from 7% now.